The integration of diagnostics and technology: Insights from global healthcare leaders

Contributing lab leaderSami YusefDr. Pauline Erica Tay & Dr. SaeYun Baik

The diagnostic landscape is undergoing a profound transformation, leveraging advanced technologies to enhance disease detection and diagnosis and extend life expectancy. Health organizations are exploring innovative solutions that improve the accuracy of disease identification and advance capabilities in predicting diseases, prognosis, and continuous patient monitoring.

At Roche Experience Days (RED) 2023, three leaders in healthcare – Mr. Sami Yusef, Chair of Corporate Development, Mayo Clinic, Dr. Pauline Erica Tay, Director, National Health Innovation Centre (NHIC), Consortium for Clinical Research & Innovation Singapore (CRIS), and Dr. SaeYun Baik, Vice President & Medical Director, SCL Healthcare & Seoul Clinical Laboratories (SCL), South Korea – provided critical insights into how technology is disrupting the future of healthcare industry.

Article highlights:

  • Diagnostics are adapting to the evolving healthcare landscape, influenced by the needs of physicians, payers, and patients.
  • Artificial intelligence and data-driven healthcare are enabling countries to reduce chronic disease and extend life expectancy.
  • Automation and robotics, digital pathology, and big data and analytics are shifting laboratory medicine and the diagnostic landscape.
animated speaking bubble

Join our community and stay up to date with the latest laboratory innovations and insights.

Subscribe now

Emerging trends in diagnostic technologies


Today, diagnostics are actively shaped by the evolving healthcare ecosystem, reflecting physicians' practices, payers' considerations, and patient preferences, according to Mr Yusef. The current challenge within the diagnostic space lies in managing the overwhelming influx of information and data as healthcare transitions from episodic, acute care to a more predictive, preventative, personalized, and participatory model, exemplified by the paradigm shift observed during the COVID-19 pandemic.

In the contemporary healthcare landscape, “diagnostics can no longer be just simply detection, but needs to be part of the whole country’s continuum of care,” says Mr. Yusef. The focus of diagnostics now extends beyond identifying diseases when symptoms manifest to embracing tools that enable prediction, prognosis, and continuous patient monitoring throughout their healthcare journey. To that end, the evolution of telemedicine and at-home tests, particularly in symptom data collection, will play a critical role in the future of diagnostics.

While next-generation sequencing has been a key driver for diagnostic tools and personalized medicines like cell and gene therapies, scalability and costs remain formidable. According to Mr. Yusef, leaders must devise solutions to identify and stratify patients who stand to benefit the most from these personalized therapies.

Furthermore, understanding diagnostic trends necessitates a nuanced evaluation of geographic locations. For example, innovations and trends in North America may differ significantly from those in Europe or Southeast Asia, reflecting diverse standards in access, cost containment, outcomes-based medicine, and population health strategies.

As the field of diagnostics evolves, Mr. Yusef points out that while the future is bright, healthcare leaders need to consider possible regulatory changes, cross-border data privacy, and accessibility to ensure that their innovative solutions are quickly adopted and integrated.

If you want to hear more from Mr. Yusef, click here to watch his full presentation at RED 2023.


Innovative development through technology


Singapore is known as the World's 6th Blue Zones Region, an area with some of the lowest rates of chronic diseases and an extended life expectancy compared to the rest of the world.1 As a leader in healthcare in Singapore, Dr. Tay informs healthcare leaders how technological innovation, including artificial intelligence (AI) and data-driven healthcare, helped Singapore reach Blue Zone status. 

In the past, technology, including digitalization, primarily facilitated simple tasks such as payments and electronic medical records. However, Singapore is now leveraging technology to transform the communication dynamics between patients and doctors, allowing them to connect, even when they don't physically visit clinical facilities.2 “Technology is changing the face of healthcare, patient outcomes, and health outcomes,” said Dr. Tay.

Dr. Tay discusses “3 Beyonds,” approaches that Singapore is integrating, shifting beyond curative care to preventative care:

  • Diagnostic tools for early detection and disease management

  • Community-based care for step-down and long-term treatment

  • Value-based healthcare that uses artificial intelligence and automation

To effectively minimize the duration of illness among its population, countries need to reduce healthcare expenses, alleviate the burden on the health system, and foster a healthier, more productive workforce. When individuals enjoy quality health and well-being, they are not only capable of working for extended periods but can also make substantial contributions to the overall economy, according to Dr. Tay. 

If you want to hear more from Dr. Tay, click here to watch her full presentation at RED 2023.


Paradigm shifts in laboratory medicine


Laboratory medicine plays a crucial role in diagnosing and monitorring patients' health conditions. Today, advanced digital technologies enable a paradigm shift in how laboratory medicine integrates with clinical trials, drug discovery, and clinical pathology.3

In her RED talk, Dr. Baik highlights technologies and areas that can digitally transform laboratory medicine, which include:

  • Laboratory information management systems (LIMS)

  • Automation and robotics

  • Digital pathology

  • Electronic health records

  • Big data and analytics

  • Telemedicine and remote monitoring

  • Point-of-care testing

  • Quality control assurance

  • Patient engagement 

  • Research and development

According to Dr. Baik, using digital tools in other areas, such as pathology and decentralized clinical trials, can improve patient data collection, engagement, and analytics. If you want to hear more from Dr. Baik, click here to watch her full presentation at RED 2023.


Novel diagnostic technologies and the future of healthcare


The future of diagnostics holds tremendous promise as novel technologies continue to advance. Cutting-edge innovations and technologies, such as single-cell multiomics, artificial intelligence, and digital laboratory medicine, are poised to revolutionize the diagnostic landscape. These advancements have the potential to bring reliable precision, speed, and personalization to the entire healthcare industry. 

Through innovations in point-of-care diagnostics, telehealth solutions, and lab medicine, healthcare is poised to transform into a seamless, patient-centric model where early detection, precise prognoses, and customized treatment plans are standard practices.

If you want to hear more from experts as they discuss the ever-changing field of diagnostics, click here to explore the presentations from RED 2023.

Want to be the first to receive the latest insights from industry leaders? Sign up for our newsletter.